Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
Hormonal crises are a rare but increasingly recognized phenomenon following peptide receptor radionuclide therapy (PRRT) in patients with neuroendocrine neoplasms (NENs). Due to the paucity of published studies, approaches to the identification, prevention, and management of risk factors are inconsistent between different institutions. This consensus statement aimed to provide guidance for NEN patients undergoing PRRT. Our statement has been created on the basis of clinical demand and concerns regarding the precipitation of hormonal crises. A formal literature review was conducted to identify available studies. A total of 19 Australian and New Zealand experts in the fields of medical oncology, nuclear medicine, anaesthetics, and endocrinology collaborated on this consensus statement. The main focus is on carcinoid crises. Other hormonal crises seen in patients with functional pancreatic NENs are addressed briefly. These recommendations are relevant to PRRT centres internationally and should be tailored to local experience and available resources.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1159/000526848 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Phenotypic spectrum and diagnostic challenges in non-21-alpha-hydroxylase deficiency congenital adrenal hyperplasia: a case series from a tertiary care center.
Endocr Regul
January 2025
Department of Endocrinology and Metabolism, Sri Ramachandra Institute of Higher Education and Research, Chennai, India.
The aim of the present study was 1) to describe the phenotypic spectrum of non-21-alfa-hydroxylase deficiency (non-21-OHD) congenital adrenal hyperplasia (CAH) encountered in a tertiary care endocrine center; 2) to identify the key biochemical, hormonal, and genetic markers that aid in differentiating non-21-OHD CAH subtypes; 3) to highlight the diagnostic challenges faced in distinguishing non-21-OHD CAH from classic 21OHD CAH and other adrenal disorders; and 4) to discuss the clinical implications and management challenges associated with non-21-OHD CAH. A retrospective analysis identified 13 cases of non-21-OHD CAH out of 87 CAH patients between 2008 to 2022. Clinical, biochemical, imaging and genetic data were analyzed.
View Article and Find Full Text PDFNonclassical Congenital Adrenal Hyperplasia Presenting With Isolated Hirsutism in a Young Adult: A Case Report.
Cureus
July 2025
Endocrinology, Diabetes and Metabolism, University of California Los Angeles David Geffen School of Medicine, Los Angeles, USA.
Congenital adrenal hyperplasia (CAH) comprises a group of autosomal recessive disorders caused by enzymatic deficiencies in adrenal steroidogenesis, resulting in impaired cortisol biosynthesis. These deficiencies may manifest as ambiguous genitalia in neonates, salt-wasting crises, or hirsutism in women. Although CAH is typically diagnosed in infancy or early childhood, nonclassical (late-onset) forms may present later in life.
View Article and Find Full Text PDFCombined in vivo and silico assessment of melatonin's protective effects on rifampicin-induced liver damage in rats.
Sci Rep
August 2025
Department of Pharmacology, Faculty of Veterinary Medicine, Cairo University, Giza, Egypt.
Liver injury is a globally serious problem that may be observed post-chemotherapeutic administration in chronic crises such as tuberculosis (TB). Rifamycin (RIF), particularly, is an indispensable treatment regimen for TB with a significant negative hepatic impact. Therefore, this research aims to assess the restorative role of melatonin (MEL) against rifampicin (RIF)-associated hepatic damage in rats.
View Article and Find Full Text PDFAccording to long-term studies, patients with adrenal insufficiency (AI) exhibit a reduced quality of life and increased mortality. In addition to cardiovascular and malignant diseases, the risk of mortality is particularly increased by adrenal crises. Fatal adrenal crises could be completely prevented by timely intravenous or subcutaneous administration of glucocorticoids.
View Article and Find Full Text PDFA Comparative Study of Dexamethasone and Methylprednisolone in COVID-19 Patients: Clinical Outcomes and Inflammatory Markers.
Recent Adv Inflamm Allergy Drug Discov
July 2025
Department of Internal Medicine, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.
Background: The Coronavirus disease 2019 (COVID-19) pandemic, prompted by SARS-CoV-2, has created complicated health crises. An excessive inflammatory response and cytokine storm characterize severe COVID-19. Corticosteroids like dexamethasone and methylprednisolone are used for their anti-inflammatory effects, but comparisons of their efficacy are lacking.
View Article and Find Full Text PDF